Results: 2

1.
Figure 2

Figure 2. From: Ventricular tachycardia in infants with structurally normal heart: a benign disorder.

Kaplan–Meier survival-type plot showing the number of days to ventricular tachycardia resolution stratified by those receiving outpatient anti-arrhythmic medications and those receiving no outpatient anti-arrhythmic medication. Log-rank statistic shows no statistical difference between survival plots (log-rank test = 1.735, p = 0.1877).

Mark D. Levin, et al. Cardiol Young. ;20(6):641-647.
2.
Figure 1

Figure 1. From: Ventricular tachycardia in infants with structurally normal heart: a benign disorder.

Anti-arrhythmic drug therapy. (a) Inpatient oral anti-arrhythmic drug usage. The graph depicts the number of infants treated with a single anti-arrhythmic agent or anti-arrhythmic drug combination; none = no inpatient oral anti-arrhythmic therapy; PRP = propranolol; AMI = amiodarone; MEX = mexiletine; PRC = procainamide. (b) Outpatient oral anti-arrhythmic drug usage. The graph depicts the number of infants treated with a single anti-arrhythmic agent or anti-arrhythmic drug combination; none = no outpatient oral anti-arrhythmic therapy; PRP = propranolol; MEX = mexiletine; AMI = amiodarone; PRC = procainamide.

Mark D. Levin, et al. Cardiol Young. ;20(6):641-647.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk